Abstract
The term “affective disorders” is used for a group of mental illnesses with a primary disturbance of affect, and comprising those behavior disorders characterized principally by increased or decreased activity and thought, expressive of a predominating mood of depression or elation.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abdulla, Y. H., and Hamadah, K. 1970. 3,5-Cyclic adenosine mono-phosphate in depression and mania. Lancet 1:378.
Akimoto, H. 1962. In Normothymics, “mood normalizers” by M. Schou. Brit. J. Psychiat. 109:803 (1963).
Akimoto, H.; Nakakuki, M.; Honda, Y.; Takahashi, Y.; and Toyoda, J. 1961. Clinical evaluation of the effect of central stimulants, MAO inhibitors, and imipramine in the treatment of affective disorders. Proceedings of Third World Congress of Psychiatry 2:958.
Andersen, H., and Kristiansen, E. S. 1959. Tofranil treatment of endogenous depression. Acta Psychiat. Scand. 34:387.
Andreani, G.; Caselle, A.; and Martelli, G. 1958. Clinical and electrographic findings in the treatment of mania with lithium salts. G. Psichiat. Neuropat. 83:273.
Angrist, B. M.; Gershon, S.; Levitan, S. J.; and Blumberg, A. G. 1968. Lithium induced “diabetes insipidus”-like syndrome. Compr. Psychiat. 11(no. 2):141.
Angst, J. 1966. Zur Aetiologie und Nosologie Endogener Depressiver Psychosen. Berlin: Springer-Verlag, p. 197.
Angst, J.; Dittrich, A.; and Grof, P. 1969. Course of endogenous affective psychoses and its modification by prophylactic administration of imipramine and lithium. Int. Pharmacopsychiat. 2:1.
Angst, J.; Weis, P.; Grof, P.; Baastrup, P.; and Schou, M. 1970. Lithium prophylaxis in recurrent affective disorders. Brit. J. Psychiat. 116(no. 535):604.
Angyal, L. 1967. Clinical experiences with the application of halopendol to mental patients. Ther. Hung. 15:155.
Annell, A. I. 1969. Lithium in the treatment of children and adolescents. Acta Psyehiat. Scand. Suppl. 207:19.
Araki, I.; Ito, M.; Kostyuk, P.; Oscarsson, O.; and Oshima, I. 1965. The effects of alkaline cations on the responses of cat spinal neurons and their removal from the cell. Proc. Roy. Soc. (Biol.) 162:319.
Aronoff, M. S., and Epstein, R. S. 1969. Lithium failure in mania: A clinical study. Read at annual meeting of American Psychiatric Association, Bal Harbor, Florida.
Atkinson, R. M., and Ditman, K. S. 1965. Tranylcypromine: A review. Clin. Pharmacol. Ther. 6:631.
Ayd, F. J. 1958. Drug-induced depression: Fact or fallacy? New York J. Med. 58:354.
Ayd, F. J. 1961. Psychopathic reactions to antidepressant drugs. J. Neuropsychiat. 2:119.
Baastrup, P. C. 1964. The use of lithium in manic-depressive psychosis. Compr. Psychiat. 5:396.
Baastrup, P. C. 1967. Report to symposium, Lithium and Goitre, Risskov, Denmark.
Baastrup, P. C., and Schou, M. 1967. Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis. Arch. Gen. Psychiat. 16:162.
Baastrup, P. C. 1968. Supplementary information about lithium treatment of manic-depressive disorders. Acta Psychiat. Scand. Suppl. 203:149.
Baastrup, P. C.; Poulson, J. C; Schou, M.; Thomsen, K.; and Amidsen, A. 1970. Prophylactic lithium: Double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 2(no. 7668):326.
Baillarger, J. 1853–1854. Note on the type of insanity with attacks characterized by two regular periods, one of depression and one of excitation. Bull. Acad. Nat. Med. (Paris) 19:340.
Baker 1930. In Foundations of Child Psychiatry. E. Miller (ed.). 1st. Ed. New York: Pergamon Press (1968), p. 262.
Baldessarini, R. J., and Stephens, J. H. 1970. Lithium carbonate for affective disorders. Arch. Gen. Psychiat. 22(no. 1):72.
Ban, T. A. 1969. The rauwolfias. In Psychopharmacology, ch. 11. Baltimore: Williams & Wilkins, p. 222.
Ban, T. A. 1969. The buterophenones. In Psychopharmacology, ch-12. Baltimore: Williams & Wilkins, p. 238.
Ban, T. A. 1969. The thioxanthenes. In Psychopharmacology, ch. 13., Baltimore: Williams & Wilkins, p. 256.
Ban, T. A.; Papathomopulos, E.; and Schwartz, L. 1962. Clinical studies with thioproperazine (Majeptil). Compr. Psychiat. 3:284.
Barsa, J. A., and Kline, N. S. 1955. Treatment of 200 disturbed psychotics with reserpine. J.A.M.A. vol. 158.
Barsa, J. A., and Saunders, J. C. 1962. Tranylcypromine in the treatment of chronic schizophrenics. Amer. J. Psychiat. 118:933.
Bauer, A. 1962. Clinical experiences with thioridazine (Mellaril) on mental syndromes. Comparison with chlorpromazine and promazine. Canad. Med. Assoc. J. 81:549.
Bennett, I. F. 1962. The constellations of depression: Its treatment with nortriptyline. II. Clinical evaluation of nortriptyline. J. Nerv. Ment. Dis. 135:59.
Bennie, R. H., and Fell, G. S. 1969. Relapses during lithium therapy. Lancet 2:1252.
Bercel, N. A. 1961. Clinical trial of thioridazine in private practice. Amer. Pract. Digest Treat. 12:44.
Berens, S. C.; Bernstein, R. S.; Robbins, J.; and Wolff, J. 1969. The antithyroid effects of lithium. Paper presented at American Thyroid Association, Chicago, Illinois.
Berens, S. C.; Wolff, J.; and Murphy, D. L. 1970. Lithium concentration by the thyroid. Submitted for publication.
Berthiaume, M. 1959. Alteration of the clinical picture during Tofranil therapy. Canad. Psychiat. Assoc. J. Suppl. 4:187.
Bratfos, O., and Haug, J. O. 1968. The course of manic depressive psychosis. Acta Psychiat. Scand. 44:89.
Brune, G. G., and Himwich, H. E. 1963. Biogenic amines and behavior in schizophrenic patients. In Recent Advances in Biological Psychiatry. J. Wortis (ed.). vol. 5. New York: Plenum Press, p. 144.
Bunney, W. E.; Brodie, H. K. H.; Murphy, D. L.; Goodwin, F. K. 1970. Studies of amine precursors and synthesis inhibitors in depression and mania. Presented to 123rd annual meeting of American Psychiatric Association, San Francisco.
Burdock, E. I., and Hardesty, A. S. 1968. A psychological test for psychopathology. J. Abnorm. Psychol. 73:62.
Cade, J. F. J. 1949. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 36:349.
Cadoret, R. J.; Winokur, G.; and Clayton, P. J. 1970. Family history studies: VII. Manic depressive disease versus depressive disease. Brit. J. Psychiat. 116(no. 535):625.
Chaffin, D. S. 1964. Phenothiazine-induced acute psychotic reaction: The “psychotoxicity” of a drug. Amer. J. Psychiat. 121:26.
Chess, S. 1970. Personal communication.
Chu, J., and Fogel, E. J. 1962. Clinical evaluation of the thymol-eptic effect of tranylcypromine. J. Indiana Med. Assoc. 56:40.
Clark, W. G., and del Giudice, J. (eds.) 1970. Principles of Psychopharmacology. New York: Academic Press.
Clarke, J. 1960. Side-effects of phenelzine. Brit. Med. J. 1:1204.
Cole, J. O. 1960. Behavioral toxicity. In Drugs and Behavior. L. Uhr and J. G. Miller (eds.). New York: John Wiley and Sons, p. 375.
Cole, L.; Griffith, C.; and Kaye, H. 1965. Anginal pain and depression. A preliminary investigation. Bis. Chest 48:584.
Cole, R. A., and Weiner, M. F. 1960. Clinical and theoretical observations on phenelzine (Nardil), an anti-depressant agent. Amer. J. Psychiat. 117:361.
Colombi, D., and Ferrio, L. 1965. Results with thioridazine administered to a group of patients with chronic psychoses. Riv. Sper. Freniat. 89:717.
Coppen, A. 1967. The biochemistry of affective disorders. Brit. J. Psychiat. 113:1237.
Coppen, A.; Prange, A. J., Jr.; Whybrow, P. C.; Noguera, R.; and Paez, J. M. 1969. Methysergide in mania, a controlled trial. Lancet 2:338.
Couleon, M.; Couleon, H.; Anne, L.; Blohorn, R.; Clerc, G.; and Guiraldo Trengualye, J. P. 1964. Treatment of states of psy-chomotor excitement, especially of acute mania by combination of thioridazine, Nembutal, and ECT. Ann. Med. Psychol. 122(II):752.
Creak, E. M. 1952. A letter. Nervous Child 9:317.
Davenport, V. D. 1950. Distribution of parenterally administered lithium in plasma, brain and muscle of rats. Amer. J. Physiol. 163:633.
D’Elia, G., and Rocco, P. G. 1963. Use of questionnaires in a clinico-pharmacological trial of Mellaril, Ann. Freniatria 76:358.
Dewhurst, W. G. 1968. Methysergide in mania. Nature 219(no. 5153): 506.
DiMascio, A.; Meuer, R. E.; and Stifler, L. 1968. Effects of imipramine on individuals varying in level of depression. Amer. J. Psychiat. 124(suppl.):55.
DiMascio, A., and Shader, R. I. 1968. Behavioral toxicity. In Psychopharmacology: A Review of Progress — 1957–1967. D.H. Efron (ed.). Washington, D.C.: U.S. Govt. Printing Office, p. 551.
Dixon and Greeves 1885. In Foundations of Child Psychiatry. E. Miller (ed.). 1st Ed. New York: Pergamon Press (1968), p. 262.
Domino, E. F. 1968. Substituted phenothiazine antipsychotics. In Psychopharmacology: A Review of Progress — 1957–1967. D.H. Efron (ed.). Washington, D.C.: U.S. Govt. Printing Office, p. 1045.
Dousa, T., and Hechter, O. 1970. The effect of NaCl and LiCl on vasopressin-sensitive adenyl cyclase. Life Sci. 9(part I):765.
Drill, V. A. 1958. Pharmacology in Medicine. 2nd Ed. New York: McGraw-Hill.
Entwistle, C.; Taylor, R. M.; and MacDonald, I. A. 1962. The treatment of mania with haloperidol (Serenace). Journal of Mental Science 108:373.
Esplin, D. W., and Zablocka, B. 1965. Central nervous system stimulants. Ch. 18. In The Pharmacological Basis of Therapeutics. S. L. Goodman and A. Gilman (eds.). 3rd Ed. New York: MacMillan, p. 352.
Falret, J. P. 1853–1854. Clinical Lectures on Mental Medicine. General Symptomatology. Paris: Bailliere, p. 188.
Falret, J. P. 1864. On Mental Diseases. Paris; Bailliere, p. 188.
Fenichel, O. 1945. The Psychoanalytic Theory of Neurosis. New York: W. W. Norton, p. 413.
Fieve, R. 1970. Lithium studies and manic-depressive illness. Presented to 60th annual meeting of American Psychopathological Assn., New York City.
Fieve, R. R.; Platman, S. R.; and Plutchik, R.R. 1968a. The use of lithium in affective disorders. I. Acute endogenous depression. Amer. J. Psychiat. 125:487.
Fieve, R. R.; Platman, S. R.; and Plutchik, R. R. 1968b. The use of lithium in affective disorders. II. Prophylaxis of depression in chronic recurrent affective disorders. Amer. J. Psychiat. 125:492.
Filotto, J. et al. 1967. Thiothixene in the treatment of affective psychoses: A pilot study. Presented at Q.P.R.A. symposium on thioxanthenes, Montreal, Canada.
Fink, M.; Kahn, R. L.; Karp, E.; Pollack, M.; Green, M. A.; Alan, B.; and Lefkowitz, H. J. 1961. Inhalant-induced convulsions. Arch. Gen. Psychiat. 4:259.
Fish, B. 1968. Methodology in child psychopharmacology. In Psychopharmacology: A Review of Progress — 1957–1967. D. H. Efron (ed.). Washington, D.C.: U.S. Govt. Printing Office, p. 989.
Fish, B., and Shapiro, T. 1965. A typology of children’s psychiatric disorders. I. Its application to a controlled evaluation of treatment. J. Amer. Acad. Child Psychiat. 4(no. 1):32.
Fotel-Andersen, K., and Geert-Jorgensen, E. 1959. Treatment of endogenous depression with Tofranil. Ugeskr. Laeg. 121:1091.
Fries, H. 1969. Experience with lithium carbonate treatment at a psychiatric department in the period 1964-1967. Acta Psychiat. Scand. Suppl. 207:41.
Frommer, F. A. 1968. Depressive illness in childhood. In Recent Developments in Affective Disorders. A. Coppen and A. Walk (eds.). Brit. J. Psychiat. Spec. Pub. No. 2, p. 117.
Fursham, P. H. 1965. The suprarenal glands (adrenal glands). In The Ciba Collection of Medical Illustrations, Endocrine System and Selected Metabolic Diseases. F. H. Netter (ed.). Vol. 4. Ciba Pharmaceutical Co., p. 84 and 105.
Gattozzi, A. A. 1970. Lithium in the Treatment of Mood Disorders. Washington, D.C.: National Clearing House for Mental Health Information, Publication No. 5033.
Gershon, S. 1968. Use of lithium salts in psychiatric disorders. Dis. Nerv. Syst. 29:51.
Gershon, S. 1970. Lithium in mania. Clin. Pharmacol. Ther. 11:168.
Gershon, S., and Trautner, E. M. 1956. Treatment of shock dependency by pharmacological agents. Med. J. Aust. 1:783.
Gershon, S., and Yuwiler, A. 1960. Lithium ion: A specific pharmacological approach to the treatment of mania. J. Neuropsychiat. 1:229.
Glessinger, B. 1954. Evaluation of lithium in treatment of psychotic excitement. Med. J. Aust. 41:277.
Goldberg, L. I. 1964. Monoamine oxidase inhibitors. J.A.M.A. 190:456.
Goldman, D. 1966. Drugs in treatment of psychosis. In Psychiatric Drugs. P. Solomon (ed.). New York: Grune and Stratton, p. 136.
Goldstein, B. J.; Clyde, D. J.; and Caldwell, J. M. 1968. Clinical efficacy of the butyrophenones as anti-psychotic drugs. In Psychopharmacology: A Review of Progress — 1957–1967. D.H. Efron (ed.). Washington, D.C.: U.S. Govt. Printing Office, p. 1085.
Gomez-Reino y Filgueira, J., and Fernandez-Vincente, L. 1962. Our experiences with Mellaril in endogenic manic and in chronic paranoid schizophrenia. Actas Luso Esp. Neurol. Psiquiat. p. 159.
Goodman, L. S., and Gilman, A. Z. 1956. The Pharmacological Basis of Therapeutics. 2nd Ed. New York: MacMillan.
Goodwin, F. K.; Murphy, D. L.; and Bunney, W. E., Jr. 1968. Lithium in mania and depression: A double-blind behavioral and biochemical study. Presented to annual meeting, American Psychiat. Assoc, Boston.
Gradwell, G. B. 1960. Psychotic reactions and phenelzine. Brit. Med. J. 2:1018.
Greenfield, I.; Zuger, M.; Bleak, R. M; and Bakal, S. F. 1950. Lithium chloride intoxication. New York J. Med. 50:459.
Greenspan, I.; Green, R.; and Durrell, J. 1968. Retention and distribution patterns of lithium, a pharmacological tool in studying the pathophysiology of manic-depressive psychosis. Amer. J. Psychiat. 125:512.
Gross, H., and Kaltenback, E. 1961. Erfahrung mit dem Thioxanthenderivat Chlorprothixen in der klinischen Psychiatrie. Wien. Klin. Wschr. 73:64.
Guistino, P. 1953. II citrato di litio mel trattamento degli stati di eccitazione psicotica. Note Psychiat. 79:307.
Haefner, H.; Heyder, B.; and Kitscher, I. 1965. Undesirable side-effects and complications with the use of neuroleptic drugs. Int. J. Neuropsychiat. 1:46.
Hamilton 1903. In Foundations of Child Psychiatry. E. Miller (ed.) 1st Ed. New York: Pergamon Press (1968).
Harms, E. 1952. Differential pattern of manic-depressive disease in childhood. Nervous Child 9:326.
Hartigan, G. P. 1963. The use of lithium salts in affective disorders. Brit. J. Psychiat. 109:810.
Haskovec, L., and Rysanek, I. 1967. The action of reserpine in imipramine resistant depressed. Psychopharmacologia (Berlin) 11:18.
Haskovec, L., and Soucek, I. 1968. Trial of methysergide in mania. Nature 219(no. 5153):507.
Hekimian, L. J., and Gershon, S. 1967. Thioxanthenes: Some clinical and physiologic effects of a thioxanthene derivative, thio-thixene, in twenty newly hospitalized male schizophrenics. J. Clin. Pharmacol. 7:52.
Hekimian, L. J.; Gershon, S.; Hardesty, A. S.; and Burdock, E. I. 1969. Drug efficacy and diagnostic specificity in manic-depressive illness and schizophrenia. Bis. Nerv. Syst. 30:747.
Heninger, G. R., and Mueller, P. S. 1970. Carbohydrate metabolism in mania. Arch. Gen. Psychiat. 23:310.
Herrera, J. J., and Vilaprino, J. J. 1964. Thioridazine in the treatment of manic-depressive psychosis. Acta Psiquiat. Psicol. Amer. Lat. 10:214.
Ho, A. K. S.; Loh, H.; Craves, F.; Hitzeman, R.; and Gershon, S. 1970. The effect of prolonged lithium treatment on the synthesis rate and turnover of monoamines in brain regions of rats. Europ. J. Pharmacol. 10:72.
Hohn, R.; Gross, G. M.; Gross, M; and Lasagna, L. 1961. A double-blind comparison of placebo and imipramine in the treatment of depressed patients in a state hospital. J. Psychiat. Res. 1:76.
Hollister, L. E. 1957. Complications from the use of tranquilizer drugs. New Eng. J. Med. 257:170.
Hospital Tribune. Sept. 21, 1970, p. 3.
Hudgens, R. W.; Tanna, V. L.; Harley, J. D.; and Leary, D. J., Jr. 1966. Visual hallucinations with iminodibenzyl antidepressants. J.A.M.A. 198:81.
Imlah, N. W. 1960. Overshooting action of phenelzine. Lancet 1:826.
Innes, I. R., and Nickerson, M. 1965. Anti-muscarinic or atropinic drugs. In The Pharmacological Basis of Therapeutics. S. L. Goodman and A. Gilman (eds.). 3rd Ed. New York: MacMillan, p. 521.
Itil, T. 1968. Early clinical and EEG drug evaluation studies. Psychiatric Research Foundation of Missouri (St. Louis) Publication No. 19. Presented at Early Clinical Drug Evaluation Units meeting, Miami, Fla.
Jacobsen, J. E. 1965. The hypomanic alert: A program designed for greater therapeutic control. Amer. J. Psychiat. 122:295.
Jarvik, M. E. 1965. Drugs used in treatment of psychiatric disorders. In The Pharmacological Basis of Therapeutics. S. L. Goodman and A. Gilman (eds.). 3rd Ed. New York: MacMillan, p. 178.
Johnson, G.; Gershon, S.; and Hekimian, L. J. 1968. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim report. Compr. Psychiat. 9:563.
Johnson, G.; Hekimian, L.; and Gershon, S. 1970. Differential drug responsiveness in psychiatric subjects. Presented to 8th annual ACNP meeting, San Diego, California.
Johnson, G.; Maccarrio, M.; Gershon, S.; and Korein, J. 1970. The effects of lithium on EEG, behavior, and serum electrolytes. J. Nerv. Ment. Bis. 151:273.
Johnson, J., and Eilenberg, M. D. 1960. Psychotic reactions and phenelzine (Nardil). Brit. Med. J. 2:857.
Kassanin 1931. In Foundations of Child Psychiatry. E. Miller (ed.). 1st Ed. New York: Pergamon Press (1968), p. 262.
Klein, D. F. 1965. Behavioral effects of imipramine and pheno-thiazines: Implications for a psychiatric pathogenetic theory and theory of drug action. In Recent Advances in Biological Psychiatry. J. Wortis (ed.). New York: Plenum Press, vol. 7, p. 273.
Klein, D. F., and Davis, J. M. 1969. Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore: Williams & Wilkins, p. 222 and p. 313.
Kline, N. S. 1954. Use of rauwolfia serpentina benth. In Neuro-psychiatric Conditions. Ann. N.Y. Acad. Sci. 59:107.
Kline, N. S. 1968. Lithium comes into its own (editorial). Amer. J. Psychiat. 125:150.
Kloos, H. H. 1967. Experiences with neuroleptic drugs — mainly thioridazine (Mellaril R) in clinical psychiatry. Praxis 56:1434.
Kolb, L. C. (ed.). 1968. Noyes’ Modern Clinical Psychiatry. 7th Ed. Philadelphia: W. B. Saunders, p. 335.
Kraepelin, E. 1909-1913. Thieme. 8th Ed. Leipzig.
Kraepelin, E. 1913. Psychiatrie. Ein Lehrbuchfür Studierende und Ärzte. Leipzig.
Kristjansen, P. 1962. In B. Gerle (ed.): Clinical observations of the side effects of haloperidol. Acta Psychiat. Scand. 40:65 (1964).
Kruse, W., and Hoermann, M. G. 1960. Clinical evaluation of four anti-depressant drugs. Curr. Ther. Res. 2:111.
Kurland, A. A.; Cuervo, R.; and Krantz, J. C., Jr. 1960. The intravenous use of hexafluorodiethyl ether as a convulsant in psychiatric treatment. J. Neuropsychiat. 1:260.
Lang, A. E., and Moore, R. A. 1961. Acute toxic psychosis concurrent with phenothiazine therapy. Amer. J. Psychiat. 117:939.
Lasky, J. J.; Klett, J. C.; Caffey, E. M.; Bennet, L. J.; Rosenblum, M. P.; and Hollister, L. E. 1962. Drug treatment of schizophrenic patients. Dis. Nerv. Syst. 23:698.
Laurell, B., and Ottosson, L. J. D. 1968. Prophylactic lithium? Letter to the editor. Lancet 2:1245.
Lehmann, H. E., and Ban, T. A. 1970. Clinical use of other anti-psychotic agents. In Principles of Psychopharmacology. W. G. Clark and J. del Giudice (eds.). New York: Academic Press, p. 621.
Lehmann, H. E., and Hanrahan, G. E. 1954. Chlorpromazine, a new inhibiting agent for psychomotor excitement and manic states. Arch. Neurol. 71:227.
Leonhard, K. 1957. Aufteilung der Endogenen Psychosen. 1st Ed. Berlin.
Leonhard, K. 1966. Aufteilung der Endogenen Psychosen. 3rd Ed. Berlin.
Lipkin, K. M.; Dyrud, J.; and Meyer, G. G. 1970. The many faces of mania. Arch. Gen. Psychiat. (Chicago)22:262.
Luby, E. 1968. Reserpine-like drugs — clinical efficacy. In Psychopharmacology: A Review of Progress —1957-1967. D. H. Efron (ed.). Washington, D. C: U.S. Govt. Printing Office, p. 1077.
Maggs, R. 1963. Treatment of manic illness with lithium carbonate. Brit. J. Psychiat. 109:56.
Malitz, S.; Hough, P. H.; and Lesse, S. 1956. Two year evaluation of chlorpromazine in clinical research and practice. Amer. J. Psychiat. 113:540.
Massaut, C.; Chantraine, J.; Meunce, E.; Pairoux, R.; Paguay, J.; Arnould, F.; Burton, P.; Tinant, M.; and Piersotte, J. 1962. Clinical study of 162 patients treated with a new neuroleptic: clopenthixol (Sordinol R), Acta Neurol. Belg. 62:651.
Mayer-Gross, W.; Slater, E.; and Roth, M. 1969. Clinical Psychiatry. 3rd Ed. London: Bailliere, Tindall & Cassell, p. 232.
Mayfield, D., and Brown, R. G. 1966. The clinical laboratory and elec-troencephalographic effects of lithium. J. Psychiat. Res. 4:207.
McCabe, M. S.; Reich, T.; and Winokur, G. 1970. Methysergide as a treatment for mania. Amer. J. Psychiat. 127:354.
McNeil Laboratories 1970. Personal communication, V. Slotnick.
Melia, P. I. 1967. A pilot trial of lithium carbonate in recurrent affective disorders. J. Irish Med. Assoc. 60:160.
Melia, P. I. 1970. Prophylactic lithium: A double-blind trial in recurrent affective disorders. Brit. J. Psychiat. 116:621.
Meyler, L. 1966. Side effects of drugs: Adverse reactions as reported by the medical literature of the world 1963-1965. Vol. 5. New York: Excerpta Medica Foundation, p. 16.
Miller, E. 1968. The problem of classification in child psychiatry. In Foundations of Child Psychiatry. 1st Ed. E. Miller (ed.). New York: Pergamon Press.
Mills 1888. In Foundations of Child Psychiatry. E. Miller (ed.). 1st Ed. New York: Pergamon Press, p. 262.
Moracci, E. 1931. Azione di alcuni sali applicati direttamente sui centri corticali sensitivo — motori del cane. Arch. Fisiol. 29:487.
Murphy, D. L.; Goodwin, F. K.; and Bunney, W. E. 1969. Aldosterone and sodium response to lithium administration in man. Lancet 2:458.
Noack, C. H., and Trautner, E. M. 1951. Lithium treatment of manic psychosis. Med. J. Aust. 2:219.
Noyes, A. P. 1954. Modern Clinical Psychiatry. 4th Ed. Philadelphia: W. B. Saunders.
O’Connell, R. A. 1970. Leucocytosis during lithium carbonate treatment. Int. Pharmacopsychiat. 4:30.
Penrose, L. 1945. Survey of cases of familial mental illness. Unpubl. manuscript, Ontario Dept. of Health.
Perris, C. 1966. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiat. Scand. Suppl., p. 189.
Pfeiffer, C. Z.; Singh, M.; and Goldstein, L. 1969. Single dose-effect relationship of lithium on the electrical activity of cerebral cortex and of the heart. J. Clin. Pharmacol. 9:298.
Pilkington, T. L. 1962. A report on Tofranil. Mental Deficiency 66:729.
Platman, S. R. 1970. A comparison of lithium carbonate and chlor-promazine in mania. Amer. J. Psychiat. 127:351.
Platman, S. R., and Fieve, R. R. 1968. Lithium carbonate and plasma cortisol response in the affective disorders. Arch. Gen. Psychiat. 18:591.
Plenge, P.; Mellerup, E. T.; and Rafaelsen, O. J. 1969. Effects of lithium on carbohydrate metabolism. Lancet 1:1012.
Poldinger, W. 1963. Combined administration of desipramine and reserpine or tetrabenazine in depressed patients. Psychophar-macologia (Berlin) 4:308.
Radomski, J. L.; Fuyat, H. N.; Nelson, A. A.; and Smith, P. K. 1950. The toxic effects, excretion and distribution of lithium chloride. J. Pharmacol. Exp. Ther. 100:429.
Ramsden, E. N. 1970. Cyclic A.M.P. in depression and mania. Lancet 2:108.
Rapp, M. S. 1970. Prophylactic haloperidol in incipient hypomania. Canad. Psychiat. Assoc. J. 15:73.
Redlich, F. C., and Freedman, D. X. 1966. The Theory and Practice of Psychiatry. New York: Basic Books.
Rees, L., and Davies, B. 1965. A study of the value of haloperidol in the management and treatment of schizophrenic and manic patients. Int. J. Neuropsychiat. 1:263.
Rikovsky, S. 1964. Incidence of imipramine-induced psychoses. Acta Nervosa Superior. 6:181.
Rissetto, G., and Gazzano, G. 1952. Variazioni del sangue periferi-co nella intossicazione sperimentale da sali di litio. Riv. Patol. Clin. 7:202.
Rochford, J. M.; Detre, T.; Tucker, G. J.; and Harrow, M. 1970. Neuropsychological impairments in functional psychiatric disease. Arch. Gen. Psychiat. 22:114.
Samuels, A. J. 1951. Primary and secondary leucocyte changes following the intramuscular injection of epinephrine hydrochloride. J. Clin. Invest. 30:941.
Sandoz Pharmaceuticals 1970. Computer search — personal communication, K. Tashiro.
Saran, B. M. 1969. Lithium. Letter to the editor. Lancet 1:1208.
Sargent, W., and Slater, E. 1963. An Introduction to Physical Methods of Treatment in Psychiatry. London: Livingstone.
Sarwer-Foner, G. J.; Grauer, H.; MacKay, J.; and Koranyi, E. K. 1959. Depressive states and drugs. A study of the use of imipra-mine “Tofranil” in open psychiatric settings. Med. Serv. J. Canada 15:359.
Sarwer-Foner, G. J.; Koranyi, E. K.; Meszaros, A.; and Grauer, H. 1959. Depressive states and drugs. II. The study of phenelzine dihydrogen sulfate (Nardil) in open psychiatric settings. Canad. Med. Assoc. J. 81:9.
Schiele, B. C. 1967. Studies with clopenthixol and thiothixene. Presented to Symposium of the Thioxanthines, Montreal, Canada.
Schou, M. 1957. Biology and pharmacology of the lithium ion. Pharmacological Reviews 9:17.
Schou, M. 1958. Lithium studies. 1. Toxicity. Acta Pharmacol. 15:70.
Schou, M. 1958. Lithium studies. 3. Distribution between serum and tissues. Acta Pharmacol. 15:115.
Schou, M. 1959. Lithium in psychiatric therapy. Psychopharmaco-logia (Berlin) 1:65.
Schou, M. 1962. Electrocardiographic changes during treatment with lithium and with drugs of the imipramine-type. Acta Psychiat. Scand. 38:331.
Schou, M. 1968. Lithium in psychiatry — A review. Psychopharmacology: A Review of Progress — 1957–1967. D. H. Efron (ed.). Washington, D.C.: U.S. Govt. Printing Office, p. 701.
Schou, M. 1970. Personal communication in Lithium in the Treatment of Mood Disorders by A. Gattozzi. Washington, D.C.: National Clearing House for Mental Health Information, Publ. No. 5033, p. 81.
Schou, M. 1970. Use of lithium. In Principles of Psychopharmacology. N. G. Clark and J. del Giudice (eds.). New York: Academic Press, p. 653.
Schou, M.; Amidsen, A.; Jensen, S. E.; and Olsen, T. 1968. Occurrence of goitre during lithium treatment. Brit. Med. J. 3:710.
Schou, M.; Juel-Nielson, N.; Stromgren, E.; and Voldby, H. 1954. The treatment of manic psychoses by the administration of lithium salts. J. Neurol. Neurosurg. Psychiat. 17:250.
Sedvall, G.; Jonsson, B.; Pettersson, U.; and Levin, K. 1968. Effects of lithium salts on plasma protein bound iodine and uptake of I-131 in thyroid gland of man and rat. Life Sci. 7:1257.
Serry, M. 1969. Lithium retention and response. Lancet 1:1267.
Sharpless, S. K. 1965. Hypnotics and sedatives. In The Pharmacological Basis of Therapeutics. S. L. Goodman and A. Gilman (eds.). 3rd Ed. New York: MacMillan, p. 132.
Sher, N. 1962. Hallucinations after chlorpromazine in an otosclero-tic. Amer. J. Psychiat. 118:746.
Sherman, S. 1961. A clinical evaluation of Mellaril. Amer. J. Psychiat. 118:452.
Shopsin, B. 1970. Effects of lithium on thyroid function. Dis. Nerv. Syst. 31:237.
Shopsin, B.; Blum, M.; and Gershon, S. 1969. Lithium-induced thyroid disturbance: Case report and review. Compr. Psychiat. 10:215.
Shopsin, B.; Friedman, R.; and Gershon, S. 1970. The lithium ion related and blood dyscrasias. Submitted for publication.
Shopsin, B., and Gershon, S. 1970. Cortisol response to dexametha-sone suppression in hospitalized depressives and control patients. Arch. Gen. Psychiat. In press.
Shopsin, B.; Gershon, S.; and Pinckney, L. 1969. The secretion of lithium in human mixed saliva: Effects of ingested lithium on electrolyte distribution in saliva and serum. Int. Pharmacopsychiat. 2:148.
Shopsin, B.; Johnson, G.; and Gershon, S. 1970. Neurotoxicity with lithium; differential drug responsiveness. Int. Pharmacopsychiat. In press.
Shopsin, B.; Kim, S. S.; and Gershon, S. 1970. A controlled study of lithium vs. chlorpromazine in acute schizophrenics. Presented at 15th Annual Conference — V.A. Cooperative Studies in Psychiatry, Houston, Texas. Accepted for publication, Brit. J. Psychiat..
Shopsin, B.; Stern, S.; and Gershon, S. 1970. Altered carbohydrate metabolism during lithium treatment in hospitalized psychiatric patients: Absence of diagnostic specificity. Submitted for publication.
Simon, W.; Wirt, A. L.; Wirt, R. D.; and Halloran, A. V. 1965. Long term follow-up study of schizophrenic patients. Arch. Gen. Psychiat. 12:510.
Sivadon, P., and Chanoit, P. 1955. Clinical experience with lithium treatment of psychomotor excitation. Ann. Medicopsychol. 113:790.
Sletten, I. W., and Gershon, S. 1966. The premenstrual syndrome: A discussion of its pathophysiology and treatment with the lithium ion. Compr. Psychiat. 7(no. 3):198.
Spitzer, R. L.; Endicott, J.; and Fleiss, J. L. 1967. Instruments and recording forms for evaluating psychiatric status and history: rationale, method of development and description. Compr. Psychiat. 8:321.
Spring, G. K.; Schweid, D.; Gray, C.; Steinberg, J.; and Harwitz, M. 1970. A double blind comparison of lithium and chlorpromazine in the treatment of manic states. Amer. J. Psychiat. 126:1306.
Spring, G. K.; Schweid, D.; Steinberg, J.; and Bond, D. 1969. Prophylactic use of lithium carbonate? J.A.M.A. 208:1901.
Stromgren, L. S., and Stromgren, E. 1962. In Normothymics “mood normalizers” by M. Schou Brit. J. Psychiat. 109:803.
Talso, P. J., and Clarke, R. W. 1951. Excretion and distribution of lithium in the dog. Amer. J. Physiol. 166:202.
Trautner, E. M.; Morris, R.; Noack, C. H.; and Gershon, S. 1955. The excretion and retention of ingested lithium and its effect on the ionic balance of man. Med. J. Aust. 2:280.
Van der Velde, C. D., and Gordon, M. W. 1969. Manic-depressive illness, diabetes mellitus and lithium carbonate. Arch. Gen. Psychiat. 21:478.
Van der Velde, C. D. 1970. Effectiveness of lithium carbonate in the treatment of manic-depressive illness. Amer. J. Psychiat. 127:345.
Von Trostorff, S. 1968. Über die hereditäre Belastung bei den bipolaren und monopolaren phasisehen Psychosen. Schweiz. Arch. Neurochir. Psychiat. 102:235.
Wiggers, S. 1968. Lithiumpavirkning af glandula thyreoidea. Ugeskr. Laeg. 130/37:1523.
Wingard, C. 1961. Questions and answers. J.A.M.A. 175:340.
Winokur, G., and Clayton, P. 1967. Family history studies: II. Sex differences and alcoholism in primary affective illness. Brit. J. Psychiat. 113:973.
Wirt, R. D., and Simon, W. 1959. Differential Treatment and Prognosis in Schizophrenia. Springfield, Ill.: Charles C Thomas.
Wolpert, E. A., and Mueller, P. 1969. Lithium carbonate in the treatment of manic-depressive disorders. Arch. Gen. Psychiat. 21:155.
Zall, H.; Therman, P. O. G.; and Myers, J. M. 1968. Lithium carbonate: A clinical study. Amer. J. Psychiat. 125:549.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Plenum Press, New York
About this chapter
Cite this chapter
Shopsin, B., Gershon, S. (1971). Chemotherapy of Manic-Depressive Disorder. In: Ho, B.T., McIsaac, W.M. (eds) Brain Chemistry and Mental Disease. Advances in Behavioral Biology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3057-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3057-8_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3059-2
Online ISBN: 978-1-4684-3057-8
eBook Packages: Springer Book Archive